Myocardial infarct extension: occurrence, outcome, and risk factors in the Multicenter Investigation of Limitation of Infarct Size.

The occurrence, outcome, and predictors of myocardial infarct extension were determined in 848 patients with acute myocardial infarction. An increase in the level of plasma MB creatine kinase activity was used to detect extension, which occurred in 71 of 848 patients (8.4%). For these patients, hospital mortality was more than four times higher than for those without extension (30% versus 7%, P less than 0.01). However, for patients surviving the initial hospitalization, there was no significant difference in mortality during the following year (12% compared with 9%). Multivariable analyses indicated that extension was more likely to occur in patients with recurrent ischemic pain during the second hospital day, a history of previous myocardial infarction, and ST segment depression on the admission electrocardiogram. The occurrence of extension in patients with two of these risk factors was more than twice that of patients without any of the risk factors (15.1% compared with 5.8%). Patients with these risk factors should be considered for early coronary angiography and possible intervention to prevent infarct extension and its sequellae.

[1]  H. Black,et al.  Racial differences in serum creatine kinase levels. , 1986, The American journal of medicine.

[2]  R. Kleiger,et al.  Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial. , 1986, The New England journal of medicine.

[3]  R. Shemin,et al.  The creatine kinase system in normal and diseased human myocardium. , 1985, The New England journal of medicine.

[4]  W. Ganz,et al.  The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.

[5]  E. Gilpin,et al.  Prognosis after extension of myocardial infarct: the role of Q wave or non-Q wave infarction. , 1985, Circulation.

[6]  R. Ideker,et al.  Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. , 1984, Circulation.

[7]  H. Morgenstern,et al.  Epidemiologic Research: Principles and Quantitative Methods. , 1983 .

[8]  J. Coromilas,et al.  Left ventricular function and rapid release of creatine kinase MB in acute myocardial infarction. Evidence for spontaneous reperfusion. , 1983, The New England journal of medicine.

[9]  A. Buda,et al.  Myocardial infarct extension: prevalence, clinical significance, and problems in diagnosis. , 1983, American heart journal.

[10]  K. Schechtman,et al.  Recurrent Myocardial Infarction: Clinical Predictors and Prognostic Implications , 1982, Circulation.

[11]  D. Harrison,et al.  Myocardial Infarct Extension: Incidence and Relationship to Survival , 1982, Circulation.

[12]  B. Sobel,et al.  Factors presaging early recurrent myocardial infarction ("extension"). , 1981, The American journal of cardiology.

[13]  A. Hernández,et al.  Plasma creatine kinase isoenzyme determinations in infants and children. Characterization in normal patients and after cardiac catheterization and surgery. , 1980, Chest.

[14]  M. Christensen,et al.  Optimal Diagnosis in Acute Myocardial Infarction: A Cost‐effectiveness Study , 1980, Circulation.

[15]  R. Rosati,et al.  Extension of Myocardial Infarction: Incidence and Prognosis , 1979, Circulation.

[16]  J. Willerson,et al.  Detection of myocardial infarct extension by CK-B radioimmunoassay. , 1979, Circulation.

[17]  B. Sobel,et al.  Quantification of serum creatine phosphokinase isoenzyme activity. , 1974, The American journal of cardiology.

[18]  C. Rizzi Statistical Methods , 2020, Springer Theses.

[19]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.